Breast Cancer Referral Study Warns Women | The Daily Round
The UK’s fastest-growing news and insight platform for the care sector.

Looking for something specific? Try a search…

UK News

Latest Health & Social Care News

Stay up to date with the latest health and social care news from across the UK. From breaking stories and sector developments to the people, organisations and issues making the news.

Women under 50 at risk of breast cancer are not being referred, study warns

Image for illustrative purposes only and may not depict the people, service or location featured in this article.

A major UK study has found that current NHS referral criteria may be failing to identify the vast majority of women under 50 who are at increased risk of developing breast cancer.

Researchers from the University of Cambridge and the Institute of Cancer Research found that the current National Institute for Health and Care Excellence (NICE) family history criteria identified only a small proportion of younger women who later developed breast cancer. The findings have been published in the British Journal of Cancer.

The researchers analysed data from 1,258 women aged under 50 who took part in the Breast Cancer Now Generations Study between 2004 and 2011. They found that the existing NICE referral criteria identified just 1.4% of women for specialist risk assessment, despite many more going on to develop breast cancer within the following decade. Overall, the study suggests the current approach fails to identify up to 95% of younger women who later develop the disease.

The team also evaluated the BOADICEA breast cancer risk prediction model, which considers a wider range of factors including genetic information, reproductive history and lifestyle. Using this approach, around 27% of women were identified as being at higher risk—around eight times more than under the current referral system.

Researchers say a more personalised approach to risk assessment could allow women at higher risk to access enhanced surveillance, preventative medication or other interventions at an earlier stage, potentially improving outcomes. However, they acknowledge that implementing broader risk assessments would require additional NHS resources and further evaluation.

In response to the findings, NICE said it welcomes new evidence but that current data are not yet sufficient to justify changing its referral recommendations. The organisation noted that its family history guidance is already under review and that emerging evidence will continue to be considered as part of that process.

Stay informed with the stories shaping health and social care.

Register with The Daily Round for the latest sector news, inspections & reports, wellbeing content, workforce insights, expert features and practical updates—delivered free to your inbox.

Posted by:
M Ramalani
Editorial Assistant – The Daily Round

Everything You Need. In Bite-Sized Updates

Busy day? We’ve got you covered. Get FREE daily news, practical insights, opportunities and wellbeing content, carefully curated for busy health and social care professionals. Just enter your details below to get The Daily Briefing delivered straight to your inbox.

Your Information
Your Interests
By subscribing, you agree to receive emails from The Daily Round, including news, updates and other relevant communications. Your information will be processed in accordance with our Privacy Policy and Terms of Use. You can unsubscribe at any time.

Sign up to our daily briefing

You can unsubscribe at any time. Please refer to our Policies for more information.

Everything You Need. In Bite-Sized Updates

Busy day? We’ve got you covered. Get FREE daily news, practical insights, opportunities and wellbeing content, carefully curated for busy health and social care professionals. Just enter your details below to get The Daily Briefing delivered straight to your inbox.

Your Information
Your Interests
By subscribing, you agree to receive emails from The Daily Round, including news, updates and other relevant communications. Your information will be processed in accordance with our Privacy Policy and Terms of Use. You can unsubscribe at any time.